We are live on ! Find out more
Ameriprise

Ameriprise Portfolio holdings

AUM $432B
1-Year Est. Return 30.22%
 

Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.

This Fund
S&P 500
This Quarter Est. Return
-13.29%
1 Year Est. Return
+30.22%
3 Year Est. Return
+89.37%
5 Year Est. Return
+112.58%
10 Year Est. Return
+443.56%
AUM
$287B
AUM Growth
-$52.2B
Cap. Flow
-$2.77B
Cap. Flow %
-0.97%
Top 10 Hldgs %
14.09%
Holding
4,071
New
137
Increased
1,635
Reduced
1,970
Closed
191

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$513M
2
AAPL icon
Apple
AAPL
+$396M
3
TGT icon
Target
TGT
+$379M
4
LLY icon
Eli Lilly
LLY
+$351M
5
EOG icon
EOG Resources
EOG
+$351M

Sector Composition

Rank Sector Weight
1 Technology 20.82%
2 Healthcare 12.74%
3 Financials 11.16%
4 Industrials 8.55%
5 Consumer Discretionary 7.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CATX icon
3801
Perspective Therapeutics
CATX
$341M
$6K ﹤0.01%
1,800
ENDP
3802
DELISTED
Endo International plc
ENDP
$5K ﹤0.01%
11,542
-967,836
-99% -$1.23M
AKBA icon
3803
Akebia Therapeutics
AKBA
$362M
$4K ﹤0.01%
+11,198
New +$4.7K
PRSTW
3804
DELISTED
Presto Technologies, Inc. Warrant
PRSTW
$4K ﹤0.01%
38,000
+17,500
+85% +$3.37K
ADILW
3805
DELISTED
Adial Pharmaceuticals Warrant
ADILW
$4K ﹤0.01%
15,000
ASAP
3806
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$3K ﹤0.01%
925
-58
-6% -$256
CWBR
3807
DELISTED
CohBar, Inc. Common Stock
CWBR
$2K ﹤0.01%
346
NBIS
3808
Nebius Group N.V.
NBIS
$47.8B
$1K ﹤0.01%
1,486,677
-496
-0%
ABSI icon
3809
Absci
ABSI
$1.29B
-86,945
Closed -$733K
ADPT icon
3810
Adaptive Biotechnologies
ADPT
$3.85B
-648,479
Closed -$9M
AGRO icon
3811
Adecoagro
AGRO
$1.47B
-10,846
Closed -$117K
AHT
3812
Ashford Hospitality Trust
AHT
$20.9M
-1,052
Closed -$107K
ALKT icon
3813
Alkami Technology
ALKT
$1.9B
-106,602
Closed -$1.52M
AMRC icon
3814
Ameresco
AMRC
$1.09B
-3,079
Closed -$245K
ANIX icon
3815
Anixa Biosciences
ANIX
$121M
-12,400
Closed -$34K
AQN icon
3816
Algonquin Power & Utilities
AQN
$4.6B
-13,860
Closed -$197K
ARDX icon
3817
Ardelyx
ARDX
$1.25B
-14,980
Closed -$17K
LONA
3818
LeonaBio Inc
LONA
$68.5M
-58,455
Closed -$7.89M
ATLC icon
3819
Atlanticus Holdings
ATLC
$1.6B
-113,470
Closed -$5.84M
ATOM icon
3820
Atomera
ATOM
$197M
-15,344
Closed -$200K
AU icon
3821
AngloGold Ashanti
AU
$41.6B
-11,453
Closed -$273K
AVO icon
3822
Mission Produce
AVO
$1.13B
-19,912
Closed -$252K
AZEK
3823
DELISTED
The AZEK Co
AZEK
-99,599
Closed -$2.48M
BALY icon
3824
Bally's
BALY
$700M
-41,894
Closed -$1.29M
BEAM icon
3825
Beam Therapeutics
BEAM
$2.73B
-9,732
Closed -$558K

Similar funds

Ameriprise's Q2 2022 Portfolio in Review

As of Q2 2022, Ameriprise held 4,071 positions worth $287B, down 15% from $339B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Ameriprise's Q2 2022 filing shows 137 new, 1,635 increased, 1,970 reduced and 191 closed positions. Its largest new stake was Aspen Technology Inc: 409,068 shares worth $75.1M. The largest sale was Medtronic, an estimated $513M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Ameriprise's largest Q2 2022 buy was Aspen Technology Inc: 409,068 shares worth $75.1M.
  • Ameriprise added most to Wells Fargo in Q2 2022, an estimated $819M increase.
  • Ameriprise's biggest Q2 2022 reduction was Medtronic, cutting an estimated $513M.
  • Ameriprise fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $250M.
  • Ameriprise's ten largest holdings make up 14% of its $287B portfolio in Q2 2022.
  • Ameriprise opened 137 new positions and closed 191 in Q2 2022.
  • Ameriprise's portfolio value fell 15% quarter-over-quarter to $287B.

Based on Ameriprise's 13F filing for Q2 2022, filed 15 Aug 2022.